Literature DB >> 15003990

Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ.

Akio Inui1, Akihiro Asakawa, Cyril Y Bowers, Giovanni Mantovani, Alessandro Laviano, Michael M Meguid, Mineko Fujimiya.   

Abstract

Recent progress in the field of energy homeostasis was triggered by the discovery of adipocyte hormone leptin and revealed a complex regulatory neuroendocrine network. A late addition is the novel stomach hormone ghrelin, which is an endogenous agonist at the growth hormone secretagogne receptor and is the motilin-related family of regulatory peptides. In addition to its ability to stimulate GH secretion and gastric motility, ghrelin stimulates appetite and induces a positive energy balance leading to body weight gain. Leptin and ghrelin are complementary, yet antagonistic, signals reflecting acute and chronic changes in energy balance, the effects of which are mediated by hypothalamic neuropeptides such as neuropeptide Y and agouti-related peptide. Endocrine and vagal afferent pathways are involved in these actions of ghrelin and leptin. Ghrelin is a novel neuroendocrine signal possessing a wide spectrum of biological activities that illustrates the importance of the stomach in providing input into the brain. Defective ghrelin signaling from the stomach could contribute to abnormalities in energy balance, growth, and associated gastrointestinal and neuroendocrine functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003990     DOI: 10.1096/fj.03-0641rev

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  99 in total

Review 1.  Ghrelin in gastroenteric pathophysiology.

Authors:  V Locatelli; E Bresciani; I Bulgarelli; D Rapetti; A Torsello; G Rindi; V Sibilia; C Netti
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

2.  Expression of ghrelin receptor mRNA in the rat and the mouse brain.

Authors:  Jeffrey M Zigman; Juli E Jones; Charlotte E Lee; Clifford B Saper; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2006-01-20       Impact factor: 3.215

3.  Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line.

Authors:  Peter C Konturek; Grzegorz Burnat; Tilman Rau; Eckhart G Hahn; Stanislaw Konturek
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

4.  Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.

Authors:  Lorenzo Leggio; William H Zywiak; Samuel R Fricchione; Steven M Edwards; Suzanne M de la Monte; Robert M Swift; George A Kenna
Journal:  Biol Psychiatry       Date:  2014-03-25       Impact factor: 13.382

5.  Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism.

Authors:  David F Schneider; Ratnam Nookala; Taylor J Jaraczewski; Herbert Chen; Carmen C Solorzano; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2014-02-13       Impact factor: 5.344

6.  Fasting-induced increase in plasma ghrelin is blunted by intravenous alcohol administration: a within-subject placebo-controlled study.

Authors:  Lorenzo Leggio; Melanie L Schwandt; Emily N Oot; Alexandra A Dias; Vijay A Ramchandani
Journal:  Psychoneuroendocrinology       Date:  2013-09-13       Impact factor: 4.905

Review 7.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

8.  Serum ghrelin levels and gender-related indices of body composition in prepubertal children: a cross-sectional study.

Authors:  Minoo Bagheri; Sara Ansari; Gity Sotoudeh; Mahmood Mahmoudi; John R Speakman; Kurosh Djafarian
Journal:  Eur J Nutr       Date:  2014-05-08       Impact factor: 5.614

9.  Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development.

Authors:  Yan Li; Jie Hai; Lake Li; Xuehui Chen; Hua Peng; Meng Cao; Qinggui Zhang
Journal:  Endocrine       Date:  2012-07-29       Impact factor: 3.633

10.  Histopathologic and immunohistochemical sequelae of bariatric embolization in a porcine model.

Authors:  Ben E Paxton; Christopher L Alley; Jennifer H Crow; James Burchette; Clifford R Weiss; Dara L Kraitchman; Aravind Arepally; Charles Y Kim
Journal:  J Vasc Interv Radiol       Date:  2014-01-21       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.